Drug shortage: Dextrose Monohydrate 10% Injection (DEXTROSE)
FDA lists 13 presentations as Current. Availability: Unavailable (1), Available (12). Reason: Discontinuation of the manufacture of the drug. Companies: Baxter Healthcare, Fresenius Kabi USA, LLC, B. Braun Medical Inc., Otsuka ICU Medical LLC.
- Published by source
- 2022-03-01
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Baxter Healthcare
- Products
- Dextrose Monohydrate 10% Injection DEXTROSE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Check wholesalers for inventory
- This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2022-03-01
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #913 | new | 2026-10-22 | 030d8a8bd427…436b09 | 131731fd272e…f9cd8f |
Chain head: #1094 edf3be25ec2e…478842